Clotting
Also known as: Clot / Thrombus / Clot blood / Blood clot (morphologic abnormality) / Coagulation defect, unspecified / Disorder of hemostatic system (disorder) / Disorder coagulation / Coagulation disorder / Defect coagulation (NOS) / Blood coagulation disorder (disorder) / Blood Coagulation Disorders / Clotting disorder / Coagulopathies / Coagulopathy / Coagulation disorder NOS
Drug | Drug Name | Drug Description |
---|---|---|
DB06779 | Dalteparin | A low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction. |
DB01109 | Heparin | An anticoagulant indicated for thromboprophylaxis and to treat thrombosis associated with a variety of conditions such as pulmonary embolism and atrial fibrillation. |
DB08813 | Nadroparin | A low molecular weight heparin used for the prophylaxis of thrombotic events and deep vein thrombosis, and prevent unstable angina and non-Q-wave myocardial infarction. |
DB06822 | Tinzaparin | A low molecular weight heparin used for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin. |
Drug | Drug Name | Phase | Status | Count |
---|